V3 sequences and paired HIV isolates from 52 non-subtype B HIV type 1-infected patients

AIDS Research and Human Retroviruses

Volumn 26, Issue 3, 2010, Pages 365-372

  Monno, Laura ^a   Brindicci, Gaetano ^a   Saracino, Annalisa ^b   Punzi, Grazia ^a   Cibelli, Donatella ^b   Lagioia, Antonella ^a   Angarano, Gioacchino ^b  

^a UNIVERSITY OF BARI   (Italy)

^b UNIVERSITY OF FOGGIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

POL PROTEIN; VIRUS ENVELOPE PROTEIN;

AMINO ACID SEQUENCE; ARTICLE; BLOOD SAMPLING; CD4 LYMPHOCYTE COUNT; CLINICAL TRIAL; CYTOPATHOGENIC EFFECT; FEMALE; GENE SEQUENCE; GENOTYPE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN IMMUNODEFICIENCY VIRUS 1 SUBTYPE B; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; MAJOR CLINICAL STUDY; MALE; MORPHOLOGICAL TRAIT; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; STRUCTURAL GENE; SYNCYTIUM; THIRD VARIABLE REGION; UNINDEXED SEQUENCE; VIRUS ISOLATION; VIRUS LOAD; VIRUS MORPHOLOGY; VIRUS STRAIN;

AMINO ACID SEQUENCE; DNA, VIRAL; FEMALE; GENETIC VARIATION; HIV ENVELOPE PROTEIN GP120; HIV INFECTIONS; HIV-1; HUMANS; ITALY; MALE; MOLECULAR SEQUENCE DATA; PEPTIDE FRAGMENTS; RNA, VIRAL; SEQUENCE ANALYSIS;

EID: 77950253521     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/aid.2009.0224     Document Type: Article

References (19)

1. Björndal A, Deng H, Jansson M, Fiore JR, et al.: Coreceptor usage of primary human immunodeficiency virus type 1 isolates varies according to biological phenotype. J Virol 1997;71(10):7478-7487.
2. Fouchier RA, Brouwer M, Broersen SM, and Schuitemaker H: Simple determination of human immunodeficiency virus type 1 syncytium-inducing V3 genotype by PCR. J Clin Microbiol 1995;33:906-911.
3. Pollakis G, Kang S, Kliphuis A, Chalaby MI, Goudsmit J, and Paxton WA: N-linked glycosylation of the HIV type-1 gp120 envelope glycoprotein as a major determinant of CCR5 and CXCR4 coreceptor utilization. J Biol Chem 2001;276(16):13433-13441.
4. Sabri F, Chiodi F, and Fenyö EM: Lack of Correlation between V3 amino acid sequence and syncytium-inducing capacity of some HIV Type 1 isolates. AIDS Res Hum Retroviruses 1996;12:855-858.
5. Coetzer M, Cilliers T, Ping L, Swanstrom R, and Morris L: Genetic characteristics of the V3 region associated with CXCR4 usage in HIV-1 subtype C isolates. Virology 2006; 356:95-105.
6. Papuashvili MN, Novokhatsky AS, and Shcherbakova TI: Characteristics of HIV-1 env V3 loop sequences for subtype A1 variant spread in Eastern Europe. Infect Genet Evol 2005;5(1):45-53.
7. Holm-Hansen C, Grothues D, Rustad S, Røsok B, Pascu FR, and Asjö B: Characterization of HIV type 1 from Romanian children: Lack of correlation between V3 loop amino acid sequence and syncytium formation in MT-2 cells. AIDS Res Hum Retroviruses 1995;11(5):597-603.
8. Briggs DR, Tuttle DL, Sleasman JW, and Goodenow MM: Envelope V3 amino acid sequence predicts HIV-1 phenotype (co-receptor usage and tropism for macrophages). AIDS 2000;14(18):2937-2939.
9. Milich L, Margolin BH, and Swanstrom R: Patterns of amino acid variability in NSI-like and SI-like V3 sequences and a linked change in the CD4-binding domain of the HIV-1 env protein. Virology 1997;239:108-118.
10. Brindicci G, Punzi G, Lagioia A, et al.: Difficulties in classifying A=G recombinants: Methodological problems or genetic variability? AIDS Res Hum Retroviruses 2007;23(6): 840-846.
11. Peeters M, Vincent R, Perret JL, et al.: Evidence for differences in MT2 cell tropism according to genetic subtypes of HIV-1: Syncytium-inducing variants seem rare among subtype C HIV-1 viruses. J Acquir Immune Defic Syndr Hum Retrovirol 1999;20(2):115-121.
12. Brandful JA, Coetzer ME, Cilliers T, et al.: Phenotypic characterization of HIV type 1 isolates from Ghana. AIDS Res Hum Retroviruses 2007;23(1):144-152.
13. Kaleebu P, Nankya IL, Yirrell DL, et al.: Relation between chemokine receptor use, disease stage, and HIV-1 subtypes A and D: Results from a rural Ugandan cohort. J Acquir Immune Defic Syndr 2007;45(1):28-33.
14. Connell BJ, Michler K, Capovilla A, Venter WD, Stevens WS, and Papathanasopoulos MA: Emergence of X4 usage among HIV-1 subtype C: Evidence for an evolving epidemic in South Africa. AIDS 2008;22(7):896-1889
15. Johnston ER, Zijenah LS, Mutetwa S, Kantor R, Kittinunvorakoon C, and Katzenstein DA: High frequency of syncytium-inducing and CXCR4-tropic viruses among human immunodeficiency virus type 1 subtype C-infected patients receiving antiretroviral treatment. J Virol 2003; 77(13):7682-7688.
16. Resch W, Hoffman N, and Swanstrom R: Improved success of phenotype prediction of the human immunodeficiency virus type 1 from envelope variable loop 3 sequence using neural networks. Virology 2001;288:51-62.
17. Karlsson I, Antonsson L, Shi Y, et al.: HIV biological variability unveiled: Frequent isolations and chimeric receptors reveal unprecedented variation of coreceptor use. AIDS 2003;5:2561-2569.
18. Milich L, Margolin BH, and Swanstrom R: V3 loop of the human immunodeficiency virus type 1 Env protein: Interpreting sequence variability. J Virol 1993;67:5623-5634.
19. Cardozo T, Kimura T, Philpott S, Weiser B, Burger H, and Zolla-Pazner S: Structural basis for coreceptor selectivity by the HIV type 1 V3 loop. AIDS Res Hum Retroviruses 2007; 23(3):415-426